Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of New Mexico School of Medicine, MSC10 5580, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA.
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of New Mexico School of Medicine, MSC10 5580, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA.
Obstet Gynecol Clin North Am. 2014 Jun;41(2):229-39. doi: 10.1016/j.ogc.2014.02.008. Epub 2014 Mar 29.
Substance use is prevalent in the United States, especially in the reproductive age population. Even though a reduction in substance use may occur during pregnancy, some women may not alter their drug use patterns until at least pregnancy is confirmed. For these reasons, a large number of fetuses are exposed to illicit substances, including during critical stages of organogenesis. Associating illicit drug use with eventual pregnancy outcome is difficult. This article presents issues pertaining to limitations with published investigations about fetal risks and describes the most current information in humans about fetal effects from specific illicit substances.
在美国，物质滥用很普遍，尤其是在生殖年龄段的人群中。尽管怀孕期间物质滥用可能会减少，但一些女性可能至少要等到怀孕得到确认后才会改变她们的药物使用模式。由于这些原因，大量胎儿接触到包括在器官发生的关键阶段的非法物质。将非法药物使用与最终的怀孕结果联系起来是困难的。本文介绍了与已发表的关于胎儿风险的调查研究的局限性相关的问题，并描述了关于特定非法物质对胎儿影响的最新人类信息。
